Cost-Consciousness Assignment Ollie Ross DSR 2. Adherence to ACP DVT prophylaxis guidelines Objective: Evaluate adherence to ACP DVT prophylaxis guidelines.

Slides:



Advertisements
Similar presentations
Implementing NICE guidance
Advertisements

Hollie Shaner-McRae DNP RN FAAN
LHD Logo Venous Thromboembolism Reducing the Risk DATE.
Optimizing Venous Thromboembolism Prophylaxis using Physician Order Entry: Johns Hopkins Hospital Experience Michael B. Streiff, MD Associate Professor.
2012 CHEST Guideline Update VTE prophylaxis, DVT treatment, and Atrial Fibrillation LT Tabatha Welker, PharmD Pharmacy Resident, PHS Claremore Indian Hospital.
Archway Healthcare Library Critically Appraised Topic (CAT) Compression stockings and the prevention of DVT Richard Peacock.
VTE in abdominal-pelvic surgery patients
DVT PROPHYLAXIS SUNDIP PATEL 7 / 15 / BACKGROUND Deep Vein Thrombosis is a common, yet preventable peri-operative complication Highest risk in critical.
Venous Thromboembolism Prevention August Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for.
Venous Thromboembolism in the Surgical Patient: Prophylaxis and Treatment Pamela Hebbard August 11, 2005.
Prophylaxis of Venous Thromboembolism
Venous Thromboembolism (VTE) Prophylaxis Policy Mary-Anne Davies Patient Safety Specialist Accreditation Coordinator.
Venous Thromboembolism
Deep Vein Thrombosis (DVT)
Perioperative Medicine Beyond Cardiac Clearance Pamela Pride MD July 31, 2012 MUSC.
RecommendationsRecommendations Risk Recommendation Ambulation (all pts) IPC/GCS or, UFH 5000 SQ q 12 hrs or, Enoxaparin 40mg SQ daily IPC/GCS or, UFH 5000.
Best Practices in Meeting NPSG 3E-Anticoagulation Requirements MaryAnne Cronin, PharmD Assistant Director of Pharmacy Glen Cove Hospital.
The Health Roundtable 3-3c_HRT1215-Session_HANNAFORD_UNSW_NSW How many people received appropriate VTE prophylaxis? Presenter: Natalie Hannaford UNSW Innovation.
VTE Prophylaxis Alert to providers and nursing Go live June 24, 2014.
DVT Prophylaxis in Medical Patients Rog Kyle, MD MUSC 6/5/12.
1 st Qatar Conference on Safe Anticoagulation Management: New Advances & Trends Hospital Acquired VTE: Input of Nurse February 27, 2015 Lynn B. Oertel,
 Incidence rate (symptomatic): 1%  ½ occur after discharge  We don’t understand which patients are at highest risk.
Anticoagulation in Acute Ischemic Stroke. TPA: Tissue Plasminogen Activator 1995: NINDS study of TPA administration Design: randomized, double blind placebo-controlled.
Ferris State University Nursing Research Presented by: Rebecca Enright, Jiali Luc, Jenny Parish, Ashley Weststrate.
DVT/VTE Nursing Protocol (Deep Vein Thrombosis) (Venous Thromboembolism) Presented by Maribeth Desiongco MA, RN-BC 2008.
LIFEBLOOD THE Thrombosis CHARITY Venous thromboembolism – Treatment and secondary prevention Ulcus cruris Chronic PE PE DVT Post-thrombotic syndrome Death.
Medical Patients – VTE Prevention Dale W. Bratzler, DO, MPH Professor and Associate Dean, College of Public Health Professor of Medicine, College of Medicine.
Evaluating the Performance of a Previously Reported Risk Score to Predict Venous Thromboembolism: A VERITY Registry Study Denise O'Shaughnessy, Peter Rose,
Prevention Of Venous Thromboembolism In The Cancer Surgical Patient A K Kakkar Barts and the London School of Medicine and Thrombosis Research Institute,
Perioperative Medicine Beyond Cardiac Clearance Pamela Pride MD July 31, 2012 MUSC.
1 VTE Protocol Presented by: Selina Baskins, RN Quality Coordinator.
Venous Thromboembolism (VTE) Southern New Hampshire Medical Center Lynda Pittenger, RN, CPHQ Kathy Helberg, BSN,RN, CPHQ.
DEFINING THE DURATION OF ANTICOAGULATION. HOW LONG TO TREAT A DVT?
VA/DoD 2006 Clinical Practice Guideline For Screening and Management of Overweight and Obesity Guideline Summary: Key Elements.
Risk assessment for VTE
Prevention of Venous Thromboembolism 8 th ACCP Guidelines Chest 2008.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, General Medicine,
VTE Venous ThromboEmbolism. VTE – aims of this module To define the terms associated with VTE and offer maximum care to treat patients. To define the.
LIFEBLOOD THE Thrombosis CHARITY LIFEBLOOD THE Thrombosis CHARITY NICE Clinical Guideline 46.
DVT Prevention and Anticoagulant Management
Venous Thromboembolism Prophylaxis for Medical Inpatients Heather Hofmann, rev. 4/18/14 DSR2 Mini Lecture.
Chapter Seven Venous Disease Coalition Long-Term Management of VTE VTE Toolkit.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, General Medicine,
Hospital-Acquired VTE: What We Have Learned Martha J. Radford, MD Chief Quality Officer NYU Langone Medical Center September 2009.
Risk assessment for VTE Dr Roopen Arya King’s College Hospital.
Risk Assessment for VTE. Which of the following best describes you?
Prophylaxis Diagnosis Treatment Venous Thromboembolism Management.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, Pharmacy, CCE Confidential:
Quality and Patient Safety Council May 27, 2014 Presented By Susan M. Blackhurst BS, RN & Eric Jean BSN, RN, CCRN.
Peri-Operative anticoagulation /antiplatelet therapy A Shift in Paradigm BMHGT04/29/09.
Perioperative Medicine Beyond Cardiac Clearance Pamela Pride MD July 31, 2012 MUSC.
 Deep Vein Thrombosis Josh Vrona, Hunter Dolan, Erin McCann.
Venous Thromboembolism (VTE) Prophylaxis at Cesarean Section Phillip N. Rauk, MD.
Dr Thomas Lloyd F1 Dr Aman Hargehandewal Wrexham Maelor Hospital
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke Antithrombotic Therapy and Prevention of Thrombosis: ACCP Evidence-Based Clinical Practice.
Prevention of Venous Thromboembolism in Nonsurgical Patients Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention.
Prevention of Venous Thromboembolism in Orthopedic Surgery Patients Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy.
1 MMM October 2008 AVAIL ME Project Audit of Venous Thromboembolism Management in Middle East Hospitals Elham Mir,MD MPH Medical Affairs Clinical Operation.
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke Antithrombotic Therapy and Prevention of Thrombosis: ACCP Evidence-Based Clinical Practice.
Dr. Lesbia Adalgisa Rodriguez PGY3-Cook County Loyola Family Medicine Residency Program Venous Thromboembolism Prophylaxis in the Inpatient Setting.
Prevention of Venous Thromboembolism in Nonsurgical Patients Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest.
Outpatient DVT assessment & treatment Daniel Gilada.
Timing of Post-discharge Venous Thromboembolic Events and Effect of Pharmacologic Prophylaxis in Hospitalized Patients Paul J. Grant MD, Todd Greene PhD,
VTE prophylaxis Sharif-Kashani,B.MD SBMU Preventing VTE Over 12 million people in the United States are at risk of VTE due to hospitalization for major.
Venous Thromboembolism Prophylaxis for Medical Inpatients
Venous Thromboembolism Prophylaxis (VTE)
Prevention of Venous Thromboembolism in Orthopedic Surgery Patients
Bridging Anticoagulation
Venous Thromboembolism Prophylaxis in Hospitalized Patients
Algorithm, risk category assessment and prophylaxis for VTE in children. Algorithm, risk category assessment and prophylaxis for VTE in children. Altered.
Presentation transcript:

Cost-Consciousness Assignment Ollie Ross DSR 2

Adherence to ACP DVT prophylaxis guidelines Objective: Evaluate adherence to ACP DVT prophylaxis guidelines in a LBVA ward team and determine if excessive prophylaxis is being utilized

ACP Guidelines Venous Thromboembolism Prophylaxis in Hospitalized Patients: A Clinical Practice Guideline From the American College of Physicians. Qaseem, A., Chou, R., et al. Annals of Internal Medicine. 2011;155:

ACP Recommendation 1 ACP recommends assessment of the risk for thromboembolism and bleeding in medical (including stroke) patients prior to initiation of prophylaxis of venous thromboembolism (Grade: strong recommendation, moderate- quality evidence).

ACP Recommendation 1 “Many risk assessment tools are available for estimating thromboembolism risk, but the current evidence is insufficient to recommend a validated tool” Note: ACCP recommends patients at low risk for DVT/PE require NO prophylaxis

Padua Risk Assessment Model 3 points: Cancer, past VTE, immobility, thrombophilic condition 2 points: Trauma or surgery in past month 1 point: Age 70 or older, CHF, AMI, Ischemic CVA, BMI 30 or greater, hormone use, acute infectious or rheumatologic disorder Score <4 considered Low Risk

ACP Recommendation 2 ACP recommends pharmacologic prophylaxis with heparin or a related drug for venous thromboembolism in medical (including stroke) patients unless the assessed risk for bleeding outweighs the likely benefits (Grade: strong recommendation, moderate- quality evidence).

ACP Recommendation 3 ACP recommends against the use of mechanical prophylaxis with graduated compression stockings for prevention of venous thromboembolism (Grade: strong recommendation, moderate- quality evidence).

ACP Recommendation 3 “In patients at high risk for bleeding events or in whom heparin is contraindicated for other reasons, intermittent pneumatic compression may be a reasonable option, because evidence suggests that it is beneficial in surgical patients” “However, intermittent pneumatic compression has not been sufficiently evaluated as a stand-alone intervention in medical patients to reliably estimate benefits and harms”

Methods One LBVA ward team with over 10 patients was chosen at random EMR was reviewed to determine what DVT prophylaxis were ordered Patients were seen to determine if SCDs were in place

Results 11 patients; all Padua score 4 or greater 6/11 had only heparin SQ ordered 2/11 had only SCDs ordered (active bleeding/ surgery planned), but SCDs were not in place (bilateral urostomy bags/ patient refusal) 1/11 had heparin SQ and SCDs ordered but SCDs were not in place 1/11 had coumadin (A-fib) and SCDs ordered and SCDs were in place 1/11 had INR >3 (cirrhosis) so no DVT ppx was ordered

Results 2/11 had both anticoagulation and SCDs ordered, but only 1/11 was actually receiving both

Take Home Point ACP DVT prophylaxis guidelines do not recommend simultaneous use of both anticoagulation and mechanical compression devices Simultaneous use of both anticoagulation and SCDs may be superfluous